Magnetic resonance spectroscopy in common dementias

Area of Science:

• Neuroimaging and Spectroscopy
• Neurology
• Biochemistry

Background:

• Neurodegenerative dementias are associated with specific brain metabolite changes, notably elevated myoinositol and reduced N-acetylaspartate (NAA).
• In Alzheimer's disease, increased myoinositol appears to precede the decline in NAA levels.
• The NAA/myo-inositol ratio in posterior cingulate gyri correlates with Alzheimer's disease pathology burden.

Purpose of the Study:

• To highlight the utility of proton magnetic resonance spectroscopy (¹H MRS) in detecting pathophysiologic processes linked to dementia risk in mild cognitive impairment.
• To discuss the challenges in translating ¹H MRS technical advancements into clinical practice.

Main Methods:

• Utilizes proton magnetic resonance spectroscopy (¹H MRS) to assess brain metabolite concentrations.
• Analyzes changes in myoinositol and N-acetylaspartate (NAA) levels.
• Investigates the NAA/myo-inositol ratio in relation to disease burden.

Main Results:

• ¹H MRS is sensitive to early pathophysiologic changes in mild cognitive impairment, indicative of dementia risk.
• Elevated myoinositol and decreased NAA are characteristic of neurodegenerative dementias.
• A decreasing NAA/myo-inositol ratio reflects increasing Alzheimer's disease pathology.

Conclusions:

• ¹H MRS shows promise for early detection of dementia-related brain changes.
• Clinical translation of ¹H MRS is hindered by a lack of standardization for multisite studies and normative data.
• Further understanding of the pathologic basis of ¹H MRS metabolite alterations is crucial for effective clinical application.